Skip to main content
Premium Trial:

Request an Annual Quote

Scienion, Axxin Collaborate on Multiplexed Microarray Instrument Reader System

NEW YORK (GenomeWeb) –Germany's Scienion and Australia's Axxin today announced a collaboration on an instrument reader system for the analysis of multiplexed microarrays on lateral flow immunoassay strips.

The partnership brings together Scienion's picoliter dispensing technology and Axxin's capabilities in commercializing instruments for point-of-care diagnostics. The firms said that the first joint project will be to develop a colorimetric reader system for multiplexed lateral flow microarrays for POC and R&D applications.

Financial and other details of the deal were not disclosed.

"Combining our expertise and technologies means leveraging integrated solutions from two ends," Sciention CEO Holger Eickhoff said in a statement. "Multiplexing is a vital topic in lateral flow point-of-care diagnostics, and I am convinced that our collaboration will result in breakthrough products in an otherwise mature market."

In June, Scienion partnered with QuantuMDx to commercialize a molecular probe technology. A month later it partnered with Australia-based Anteo to improve reagents for protein microarrays.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.